Literature DB >> 27207902

Induction of matrix metalloproteinase-1 by tumor necrosis factor-α is mediated by interleukin-6 in cultured fibroblasts of keratoconus.

Genlai Du1, Chengxing Liu2, Xiaona Li1, Weiyi Chen1, Rui He3, Xiaojun Wang1, Pengfei Feng1, Weiwei Lan1.   

Abstract

Inflammatory molecules and matrix metalloproteinase (MMPs) have been found over-expressed in the tear film of patients with keratoconus. However, the mechanistic link between inflammatory molecules and MMPs in the pathogenesis of keratoconus remains still elusive. Therefore, we investigated the effect of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) on MMP-1 expression and used IL-6 antibody (IL-6 Ab) to examine the role of IL-6 on TNF-α mediated regulation of MMP-1 in fibroblasts of normal cornea and keratoconus. Real-time polymerase chain reaction, Enzyme-linked immunosorbent assay, and Western blot data demonstrated that MMP-1 and IL-6 were expressed in fibroblasts of normal cornea and keratoconus. Levels of MMP-1 and IL-6 were significantly higher in keratoconus than normal cornea. TNF-α treatment led to a significant increase in IL-6 levels. IL-6 treatment induced MMP-1 synthesis in normal cornea and keratoconus. TNF-α increased MMP-1 expression in a dose- and time-dependent manner and this response was completely inhibited by the IL-6 Ab. In conclusion, these results indicate that fibroblasts of keratoconus shows increased levels of IL-6 and MMP-1 gene and protein expression and IL-6 mediates the TNF-α-induced MMP-1 expression.

Entities:  

Keywords:  Corneal fibroblasts; inflammatory cytokine; keratoconus; matrix metalloproteinases (MMPs)

Mesh:

Substances:

Year:  2016        PMID: 27207902      PMCID: PMC5102130          DOI: 10.1177/1535370216650940

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  34 in total

Review 1.  Inflammation and keratoconus.

Authors:  Charles W McMonnies
Journal:  Optom Vis Sci       Date:  2015-02       Impact factor: 1.973

2.  Heat shock-induced matrix metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and JNK activation and via an autocrine interleukin-6 loop.

Authors:  Chi-Hyun Park; Min Jung Lee; Jungmi Ahn; Sangmin Kim; Hyeon Ho Kim; Kyu Han Kim; Hee Chul Eun; Jin Ho Chung
Journal:  J Invest Dermatol       Date:  2004-12       Impact factor: 8.551

3.  Up-regulation of matrix metalloproteinase-1 and interleukin-6 expression in cocultures of corneal fibroblasts and neural cells.

Authors:  Ji-Ae Ko; Tai-ichiro Chikama; Koh-Hei Sonoda; Yoshiaki Kiuchi
Journal:  Biochem Biophys Res Commun       Date:  2012-02-17       Impact factor: 3.575

4.  Regulation of MMP-9 production by human corneal epithelial cells.

Authors:  D Q Li; B L Lokeshwar; A Solomon; D Monroy; Z Ji; S C Pflugfelder
Journal:  Exp Eye Res       Date:  2001-10       Impact factor: 3.467

5.  The effects of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and transforming growth factor-beta1 on pulp fibroblast mediated collagen degradation.

Authors:  Kessiri Wisithphrom; L Jack Windsor
Journal:  J Endod       Date:  2006-07-03       Impact factor: 4.171

6.  Inflammatory molecules in the tears of patients with keratoconus.

Authors:  Isabel Lema; Juan A Durán
Journal:  Ophthalmology       Date:  2005-04       Impact factor: 12.079

Review 7.  New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression.

Authors:  Brigitte Bauvois
Journal:  Biochim Biophys Acta       Date:  2011-10-12

8.  Changes in the balance of the tissue inhibitor of matrix metalloproteinases (TIMPs)-1 and -3 may promote keratocyte apoptosis in keratoconus.

Authors:  Fiona J Matthews; Stuart D Cook; Mohammed A Majid; Andrew D Dick; Valerie A Smith
Journal:  Exp Eye Res       Date:  2007-03-07       Impact factor: 3.467

9.  Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications.

Authors:  Anne Chastre; Mireille Bélanger; Elizabeth Beauchesne; Bich N Nguyen; Paul Desjardins; Roger F Butterworth
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

10.  The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix.

Authors:  B K Pilcher; J A Dumin; B D Sudbeck; S M Krane; H G Welgus; W C Parks
Journal:  J Cell Biol       Date:  1997-06-16       Impact factor: 10.539

View more
  6 in total

1.  Histopathologic findings of keratoconus corneas underwent penetrating keratoplasty according to topographic measurements and keratoconus severity.

Authors:  Mohammad Naderan; Ali Jahanrad; Siavash Balali
Journal:  Int J Ophthalmol       Date:  2017-11-18       Impact factor: 1.779

2.  Octenidine-based hydrogel shows anti-inflammatory and protease-inhibitory capacities in wounded human skin.

Authors:  Saskia Seiser; Lukas Janker; Nina Zila; Michael Mildner; Ana Rakita; Johannes Matiasek; Andrea Bileck; Christopher Gerner; Verena Paulitschke; Adelheid Elbe-Bürger
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

3.  Systematically Displaying the Pathogenesis of Keratoconus via Multi-Level Related Gene Enrichment-Based Review.

Authors:  Xiao-Dan Hao; Hua Gao; Wen-Hua Xu; Chan Shan; Ying Liu; Zhi-Xia Zhou; Kun Wang; Pei-Feng Li
Journal:  Front Med (Lausanne)       Date:  2022-01-24

4.  Associations Between Keratoconus and the Level of Sex Hormones: A Cross-Sectional Study.

Authors:  Xiaorui Zhao; Yifei Yuan; Tong Sun; Yu Zhang; Yueguo Chen
Journal:  Front Med (Lausanne)       Date:  2022-02-24

5.  Biochemical and molecular alterations and potential clinical applications of biomarkers in keratoconus.

Authors:  Vaitheeswaran G Lalgudi; Rohit Shetty; Kanwal K Nischal; Setareh Ziai; Mona Koaik; Swaminathan Sethu
Journal:  Saudi J Ophthalmol       Date:  2022-04-09

6.  De novo mutations of TUBA3D are associated with keratoconus.

Authors:  Xiao-Dan Hao; Peng Chen; Yang-Yang Zhang; Su-Xia Li; Wei-Yun Shi; Hua Gao
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.